1. Treatment planning and medication monitoring were lacking for children in foster care receiving psychotropic medication Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2018 Subject(s): Antipsychotic Agents -- therapeutic useFoster Home CareMedication Therapy ManagementPatient Care PlanningChildChild Health Services -- standardsInappropriate PrescribingMental Disorders -- drug therapyPractice Guidelines as TopicState GovernmentHumansUnited StatesUnited States. Department of Health and Human Services.
2. Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS Buprenorphine Practice Guidelines Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 2, 2022 Subject(s): Buprenorphine -- therapeutic useDrug Prescriptions -- statistics & numerical dataDrug Utilization -- statistics & numerical dataDrug Utilization -- trendsOpioid-Related Disorders -- drug therapyPractice Guidelines as TopicScope of PracticeUnited StatesUnited States. Department of Health and Human Services.
3. DOD health care: DOD should monitor implementation of its clinical practice guidelines : report to Congressional committees Publication: Washington, DC : United States Government Accountability Office, February 2021 Subject(s): Government RegulationMilitary Health Services -- standardsPractice Guidelines as TopicUnited StatesUnited States. Department of DefenseUnited States. Department of Veterans Affairs
